Wizualizacja enzymów proteolitycznych za pomocą sond chemicznych oraz cytometrii masowej

• Autorzy: Groborz Katarzyna , Poręba Marcin

Identyfikatory

DOI

10.53584/wiadchem.2021.12.2

Warianty tytułu

EN

Visualization of proteolytic enzymes using mass cytometry : compatible chemical probes

• Języki publikacji: EN

Abstrakty

EN

Proteolytic enzymes, also known as peptidases or proteases, are protein catalysts that are primarily responsible for the hydrolysis of a peptide (amide) bond in peptide and protein substrates. By selective hydrolysis of selected substrates, these enzymes control many physiologically important processes including programmed cell death, blood coagulation cascade, protein maturation, fibrinolysis and many others. On the other hand, however, the imbalance in proteases activity leads to the development of diseases, including cancer, neurodegenerative diseases and coronary diseases etc.. In recent decades there has been great progress in studying the biological functions of many proteolytic enzymes. These observations were made possible through the use of various research techniques including genomics, epigenomics and proteomics. However, a major limitation of these techniques is the lack of information about the exact catalytic activity of the enzymes. For this reason, chemical probes are the most convenient toll for functional investigation of proteolytic enzymes. According to the generally accepted convention, chemical probes are compounds that can detect the catalytic activity of proteolytic enzymes. In general, chemical-based probes (activity-based probes, ABPs) consist of three main components: (1) a reactive binding group that binds permanently to the enzyme active site, (2) a recognition sequence (usually a peptide), which is responsible for the selective binding of a given probe to an individual enzyme or group of enzymes, and (3) a tag, mainly a fluorophore, enabling for detection of the probe-enzyme complex. However, the current limitation of ABPs is that only up to four enzymes can be detected and visualized in parallel, which significantly impedes their application for multi-parametric analysis. To date, the detection of proteases with the use of ABPs was limited to individual enzymes being investigated one by one, thus the obtained picture was far from being complete. In this review we describe the development of a new type of enzyme ABPs, so called TOF-probes that are compatible with mass cytometry format. The application of metal isotopes instead of fluorophores, makes possible to significantly increase the number of enzymes, which can be simultaneously visualized using chemical probes. Mass cytometry is a revolutionary technology that adopts atomic mass spectrometry into flow cytometry applications. The excellence of this method is that each metal isotope (mostly from lanthanides) has its own peak on mass spectrum, which eliminates the problem of signal overlap, thus allows for monitoring of more than 40 parameters at single cell level.

Słowa kluczowe

EN

chemical probe; mass cytometry; proteolytic enzymes; cancer; cell death

PL

sonda chemiczna; cytometria masowa; enzymy proteolityczne; nowotwory; śmierć komórki

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Wiadomości Chemiczne
• Rocznik: 2021
• Tom: [Z] 75, 11-12
• Strony: 1171--1191
• Opis fizyczny: Bibliogr. 35 poz., rys., schem.

Twórcy

autor

Groborz Katarzyna

• Genentech Inc. South San Francisco, USA

• https://orcid.org/0000-0002-1894-4881

autor

Poręba Marcin

• Katedra Chemii Biologicznej i Bioobrazowania, Wydział Chemiczny, Politechnika Wrocławska, Wyb. Wyspiańskiego 27, 50-370 Wrocław, Polska

• https://orcid.org/0000-0002-0214-6252

Bibliografia

• [1] N.D. Rawlings, M. Waller, A. J. Barrett, A. Bateman, Nucleic Acids Res., 2014, 42, D503.
• [2] M. Drag, G.S. Salvesen, Nat. Rev. Drug Discov., 2010, 9, 690.
• [3] B. Turk, Nat. Rev. Drug Discov., 2006, 5, 785.
• [4] X.S. Puente, L.M. Sanchez, C.M. Overall, C. Lopez-Otin, Nat. Rev. Genet., 2003, 4, 544.
• [5] I. Schechter, A. Berger, Biochem. Biophys. Res. Commun., 1967, 27, 157.
• [6] J. Zhou, S. Li, K.K. Leung, B. O’Donovan, J. Y. Zou, J.L. DeRisi, J. Wells, Proc. Natl. Acad. Sci. USA, 2020, 117, 25464.
• [7] G.P. McStay, G.S. Salvesen, D.R. Green, Cell Death Differ., 2007, 15, 322.
• [8] Y. Choe, F. Leonetti, D.C. Greenbaum, F. Lecaille, M. Bogyo, D. Bromme, J.A. Ellman, Ch. Craik, J. Biol Chem., 2006, 281, 12824.
• [9] M. Poreba, M. Drag, Curr. Med. Chem., 2010, 17, 3968.
• [10] B.I. Ratnikov, P. Cieplak, A.G. Remacle, E. Nguyen, J.W. Smith, PLoS Comput. Biol., 2021, 17, e1008101.
• [11] Poreba, G.S. Salvesen, M. Drag, Nat. Protoc., 2017, 12, 2189.
• [12] J.S. Bond, J. Biol. Chem., 2019, 294, 1643.
• [13] J.A. Joyce, A. Baruch, K. Chehade, N. Meyer-Morse, E. Giraudo, F.Y. Tsai, D. Greenbaum, J. Hager, M. Bogyo, D. Hanahan, Cancer Cell., 2004, 5, 443.
• [14] L. Akkari, V. Gocheva, M.L. Quick, J.C. Kester, A.K. Spencer, A.L. Garfall, R.L. Bowman, J.A. Joyce, Genes Dev., 2016, 30, 220.
• [15] N.A. Thornberry, T.A. Rano, E.P. Peterson, D.M. Rasper, T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom, S. Roy, J.P. Vaillancourt, K.T. Chapman, D.W. Nicholson, J. Biol. Chem., 1997, 272, 17907.
• [16] M. Fonovic, M. Bogyo, Curr. Pharm. Des., 2007, 13, 253.
• [17] M. Fonovic, M. Bogyo, Exp. Rev. Proteom., 2008, 5, 721.
• [18] J. Harkness, B.W. Roper, J.A. Durant, H. Miller, Br. Med. J., 2960, 1, 1787.
• [19] C.M. Kam, A.S. Abuelyaman, Z. Li, D. Hudig, J.C. Powers, Bioconjug. Chem., 1993, 4, 560.
• [20] A. Saghatelian, N. Jessani, A. Joseph, M. Humphrey, B.F. Cravatt, Proc. Natl. Acad. Sci. U.S.A., 2004, 101, 10000.
• [21] Y. Liu, M.P. Patricelli, B.F. Cravatt, Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 14694.
• [22] L.E. Sanman, M. Bogyo, Ann. Rev. Biochem., 2014, 83, 249.
• [23] P. Kasperkiewicz, Y. Altman, M. D’Angelo, G. S. Salvesen, M. Drag, J. Am. Chem. Soc., 2017, 139, 10115.
• [24] M. Garland, J.J. Yim, M. Bogyo, Cell Chem. Biol., 2016, 23, 122.
• [25] M. Bogyo, S. Verhelst, V. Bellingard-Dubouchaud, S. Toba, D. Greenbaum, Chem. Biol., 2000, 7, 27.
• [26] M. Poreba, K. Groborz, W. Rut, M. Pore, S.J. Snipas, M. Vizovisek, B. Turk, P. Kuhn, M. Drag, G.S. Salvesen, J. Am. Chem. Soc., 2020, 142, 16704.
• [27] K. Groborz, Rozprawa Doktorska, Politechnika Wrocławska, 2020, 1, 1.
• [28] R.L. Siegel, K.D. Miller, A. Jemal, C.A. Cancer J. Clin., 2020, 70, 7.
• [29] I. Pemberton, Conference Paper: VIII Simpar, 2016, 3, 50.
• [30] D.R. Bandura, V.I. Baranov, O.I. Ornatsky, A. Antonov, R. Kinach, X. Lou, S. Pavlov, S. Vorobiev, J.E. Dick, S.D. Tanner, Anal. Chem., 2009, 81, 6813.
• [31] S.C. Bendall, E.F.Simonds, P. Qiu, A.D. Amir el, P.O. Krutzik, R. Finck, R.V. Bruggner, R. Melamed, A. Trejo, O.I. Ornatsky, R.S. Balderas, S.K. Plevritis, K. Sachs, D. Pe'er, S.D. Tanner, G.P. Nolan, Science, 2011, 332, 687.
• [32] J. Wagner, M.A. Rapsomaniki, S. Chevrier, T. Anzeneder, C. Langwieder, A. Dykgers, M. Rees, A. Ramaswamy, S. Muenst, S.D. Soysal, A. Jacobs, J. Windhager, K. Silina, M. van den Broek, K.J. Dedes, M. Rodriguez Martinez, W.P. Weber, B. Bodenmiller, Cell, 2019, 177, 1330.
• [33] M. Poreba, R. Solberg, W. Rut, N.N. Lunde, P. Kasperkiewicz, S.J. Snipas, M. Mihelic, D. Turk, B. Turk, G.S. Salvesen, M. Drag, Cell Chem. Biol., 2016, 23, 1023.
• [34] M. Poreba, W. Rut, M. Vizovisek, K. Groborz, P. Kasperkiewicz, D. Finlay, K. Vuori, D. Turk, B. Turk, G.S. Salvesen, M. Drag, Chem. Sci., 2018, 9, 2113.
• [35] M. Poreba, K. Groborz, M. Vizovisek, M. Maruggi, D. Turk, B. Turk, G. Powis, M. Drag, G.S. Salvesen, Chem. Sci., 2019, 10, 8461.